Skip to content

Post-market clinical follow-up of a magnetic bone conduction implant (Cochlear Baha® Attract System)

Post-market clinical follow-up of a magnetic bone conduction implant (Cochlear Baha® Attract System) - Cochlear

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41439
Enrollment
25
Registered
2014-02-27
Start date
2014-03-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive or mixed hearing loss or single-sided sensorineural deafness (SSD):

Interventions

None listed

Sponsors

Cochlear Bone Anchored Solutions AB
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Adult subject, i.e. >= 18 years of age • Conductive or mixed hearing loss in the ear to be implanted: Bone conduction thresholds with a pure tone average PTA4 of

Exclusion criteria

Exclusion criteria: • Subjects that are scheduled for simultaneous bilateral implant surgery. The investigation is limited to subjects with unilateral use of the Baha Attract System (however, bilateral hearing loss is not an exclusion criterion). • Suitable implant position for the BI300 Implant (4 mm or 3 mm) not found during surgery due to insufficient bone quality and/or bone thickness. • Less than 3 mm soft tissue thickness at the planned implant site. • Subjects that have received radiation therapy at the same side of the skull where the Baha Attract System will be positioned. • Condition that could jeopardise osseointegration and/or wound healing as judged by the investigator (e.g. osteoporosis, psoriasis, use of corticosteroids). • Uncontrolled diabetes as judged by the investigator. • Condition that may have an impact on the outcome of the investigation as judged by the investigator. • Unable to follow investigational procedures (e.g. to complete quality of life scales). • Participation in another investigation with pharmaceuticals and/or medical device.

Design outcomes

Primary

MeasureTime frame
To compare the hearing performance with the Baha Attract System (aided) and the unaided hearing performance.

Secondary

MeasureTime frame
•*To compare the hearing performance with the Baha Attract System and the hearing performance with the same sound processor on a Baha Softband. •*To compare health status and health-related quality of life and utility scores before and after use of the Baha Attract System. •*To compare self-reported assessment of hearing aid outcome before and after use of the Baha Attract System. •*To collect surgical information. •*To investigate if the Sound Processor Magnet strength and magnetic force required for retention changes over time. •*To collect information regarding pain, discomfort, numbness and soft tissue status. •*To monitor implant survival. •*To collect Adverse Events and device deficiencies.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)